Metabolic research
Short answer
GLP-1R, GIPR, and GCGR are central receptors in metabolic research models. Mono-agonists (e.g. semaglutide), dual agonists (e.g. tirzepatide), and tri-agonists (e.g. retatrutide) let laboratories probe how combined incretin and glucagon signalling alters insulin secretion, glucagon suppression, and energy metabolism in preclinical systems.
GLP-1 receptor (GLP-1R)
Class B GPCR studied in pancreatic beta-cell, hypothalamic, and gastric motility models. Tool compounds include semaglutide, liraglutide, and related GLP-1 analogues.
GIP receptor (GIPR)
Incretin receptor co-studied with GLP-1R in dual-agonist research. Tirzepatide is the reference dual GLP-1/GIP agonist in many metabolic model systems.
Glucagon receptor (GCGR)
Studied in hepatic glucose output and energy expenditure models. Tri-agonists such as retatrutide add GCGR engagement to GLP-1/GIP activity in research comparisons.
HALO documentation standard
Each metabolic research SKU ships with batch COA, HPLC purity, identity confirmation, and RUO-only labelling for procurement audit trails.
Direct answers
Where can I compare GLP-1 research compounds?
See /compare/semaglutide-vs-tirzepatide/ and /compare/tirzepatide-vs-retatrutide/ for structured comparisons.
Are these materials for human metabolic treatment research?
HALO materials are RUO laboratory research compounds only — not for human or veterinary use.
Research use only. HALO materials and educational content are for qualified laboratory research only. Not for human or veterinary use.
